The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland

被引:324
作者
Davies, Andrew N. [1 ]
Dickman, Andrew [2 ]
Reid, Colette
Stevens, Anna-Marie [3 ]
Zeppetella, Giovambattista
机构
[1] Royal Marsden NHS Fdn Trust, Dept Palliat Med, Sutton SM2 5PT, Surrey, England
[2] Marie Curie Palliat Care Inst, Liverpool, Merseyside, England
[3] Royal Marsden NHS Fdn Trust, London, England
关键词
Pain; Breakthrough pain; Cancer; Palliative care; TRANSMUCOSAL FENTANYL CITRATE; PATIENT-CONTROLLED ANALGESIA; INCIDENT PAIN; INTRAVENOUS MORPHINE; HOSPICE PATIENTS; BONE METASTASES; DOSE-TITRATION; EPISODIC PAIN; DOUBLE-BLIND; CASE SERIES;
D O I
10.1016/j.ejpain.2008.06.014
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) was convened to produce some up-to-date, evidence-based, practical, clinical guidelines on the management of cancer-related breakthrough pain in adults. On the basis of a review of the literature, the task group was unable to make recommendations about an individual interventions, but was able to make a series of 12 recommendations about certain generic strategies. However, most of the aforementioned recommendations are based on limited evidence (i.e., case series, expert opinion). The task group also proposed a definition of breakthrough pain, and some diagnostic criteria for breakthrough pain. (c) 2008 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 58 条
[31]  
Laverty D, 2006, CANC RELATED BREAKTH, P23
[32]  
LUSSIER D, 2004, OXFORD TXB PALLIATIV, P349
[33]   Optimization of opioid therapy for preventing incident pain associated with bone metastases [J].
Mercadante, S ;
Villari, P ;
Ferrera, P ;
Casuccio, A .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (05) :505-510
[34]   Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose [J].
Mercadante, S ;
Villari, P ;
Ferrera, P ;
Bianchi, M ;
Casuccio, A .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 27 (04) :352-359
[35]   Episodic (breakthrough) pain - Consensus conference of an expert working group of the European Association for Palliative Care [J].
Mercadante, S ;
Radbruch, L ;
Caraceni, A ;
Cherny, N ;
Kaasa, S ;
Nauck, F ;
Ripamonti, C ;
De Conno, F .
CANCER, 2002, 94 (03) :832-839
[36]  
MERCADANTE S, 1995, REGION ANESTH, V20, P343
[37]   Breakthrough pain in cancer patients: Pathophysiology and treatment [J].
Mercadante, S ;
Arcuri, E .
CANCER TREATMENT REVIEWS, 1998, 24 (06) :425-432
[38]   Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine [J].
Mercadante, Sebastiano ;
Villari, Patrizia ;
Ferrera, Patrizia ;
Porzio, Giampiero ;
Aielli, Federica ;
Verna, Lucilla ;
Casuccio, Alessandra .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 32 (02) :175-179
[39]   Self-administered nitrous oxide for the management of incident pain in terminally ill patients: a blinded case series [J].
Parlow, JL ;
Milne, B ;
Tod, DA ;
Stewart, GI ;
Griffiths, JM ;
Dudgeon, DJ .
PALLIATIVE MEDICINE, 2005, 19 (01) :3-8
[40]   Temporal presentation of chronic cancer pain: Transitory pains on admission to a multidisciplinary pain clinic [J].
Petzke, F ;
Radbruch, L ;
Zech, D ;
Loick, G ;
Grond, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 17 (06) :391-401